Premium
Stimulant prescribing soars among U.S. women of childbearing age
Publication year - 2018
Publication title -
the brown university psychopharmacology update
Language(s) - English
Resource type - Journals
eISSN - 1556-7532
pISSN - 1068-5308
DOI - 10.1002/pu.30319
Subject(s) - stimulant , medicine , pregnancy , psychiatry , biology , genetics
Prescribing of stimulant medications for the treatment of attention‐deficit/hyperactivity disorder (ADHD) among privately insured women ages 15 to 44 increased by 388% between 2003 and 2015, according to data published in the Jan. 19 Morbidity and Mortality Weekly Report . The report authors state that this trend highlights the urgency of evaluating the safety of ADHD medication use during pregnancy, in order to help women and their health care providers in conducting a sound risk‐benefit analysis of the medications.